<p>本文由 MarketWatch 自动生成，使用了 Automated Insights 的技术。</p>
<p>Corbus Pharmaceuticals Holdings Inc. (CRBP) 的股价周四下跌 5.65%，至 9.68 美元，股市整体交易表现混合，道琼斯工业平均指数上涨 1.34%，至 48,704.01 点，而纳斯达克综合指数下跌 0.25%，至 23,593.86 点。</p>
<p>Corbus Pharmaceuticals Holdings Inc. 的股价比其 52 周高点 20.56 美元低 52.92%，该高点是在 10 月 20 日达到的。</p>
<p>与一些竞争对手相比，该股周四表现不佳，Vanda Pharmaceuticals Inc. (VNDA) 下跌 2.22%，至 6.60 美元，Fortress Biotech Inc. (FBIO) 保持不变，而 Viking Therapeutics Inc. (VKTX) 下跌 0.85%，至 37.21 美元。</p>
<p>交易量（500 万）超过其 50 天平均交易量 518,842。</p>
<p>数据来源：道琼斯市场数据，FactSet。数据编制于 2025 年 12 月 11 日。</p>
<p>此内容由 MarketWatch 创建，MarketWatch 由道琼斯公司运营。MarketWatch 独立于道琼斯新闻通讯和《华尔街日报》发布。</p>
<p>（完）道琼斯新闻通讯</p>
<p>12-11-25 1723ET</p>

Corbus制药控股

<p>Corbus 制药控股公司 (CRBP) 的股票在周四下跌了 5.65%，至 9.68 美元，表现不及一些竞争对手。该股票比其 52 周高点 20.56 美元低了 52.92%。交易量显著高于 50 日平均水平。在此期间，道琼斯指数上涨了 1.34%，而纳斯达克指数下跌了 0.25%</p>

<p>This article was automatically generated by MarketWatch using technology from Automated Insights.</p>
<div class="lb-trans"><p>本文由 MarketWatch 自动生成，使用了 Automated Insights 的技术。</p>
</div><p>Shares of Corbus Pharmaceuticals Holdings Inc. (CRBP) slipped 5.65% to $9.68 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 1.34% to 48,704.01 and the NASDAQ Composite Index falling 0.25% to 23,593.86.</p>
<div class="lb-trans"><p>Corbus Pharmaceuticals Holdings Inc. (CRBP) 的股价周四下跌 5.65%，至 9.68 美元，股市整体交易表现混合，道琼斯工业平均指数上涨 1.34%，至 48,704.01 点，而纳斯达克综合指数下跌 0.25%，至 23,593.86 点。</p>
</div><p>Corbus Pharmaceuticals Holdings Inc. closed 52.92% below its 52-week high of $20.56, which the company reached on October 20th.</p>
<div class="lb-trans"><p>Corbus Pharmaceuticals Holdings Inc. 的股价比其 52 周高点 20.56 美元低 52.92%，该高点是在 10 月 20 日达到的。</p>
</div><p>The stock underperformed when compared to some of its competitors Thursday, as Vanda Pharmaceuticals Inc. (VNDA) fell 2.22% to $6.60, Fortress Biotech Inc. (FBIO) remained unchanged, and Viking Therapeutics Inc. (VKTX) fell 0.85% to $37.21.</p>
<div class="lb-trans"><p>与一些竞争对手相比，该股周四表现不佳，Vanda Pharmaceuticals Inc. (VNDA) 下跌 2.22%，至 6.60 美元，Fortress Biotech Inc. (FBIO) 保持不变，而 Viking Therapeutics Inc. (VKTX) 下跌 0.85%，至 37.21 美元。</p>
</div><p>Trading volume (5.0 M) eclipsed its 50-day average volume of 518,842.</p>
<div class="lb-trans"><p>交易量（500 万）超过其 50 天平均交易量 518,842。</p>
</div><p>Data source: Dow Jones Market Data, FactSet. Data compiled December 11, 2025.</p>
<div class="lb-trans"><p>数据来源：道琼斯市场数据，FactSet。数据编制于 2025 年 12 月 11 日。</p>
</div><p>This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.</p>
<div class="lb-trans"><p>此内容由 MarketWatch 创建，MarketWatch 由道琼斯公司运营。MarketWatch 独立于道琼斯新闻通讯和《华尔街日报》发布。</p>
</div><p>(END) Dow Jones Newswires</p>
<div class="lb-trans"><p>（完）道琼斯新闻通讯</p>
</div><p>12-11-25 1723ET</p>
<div class="lb-trans"><p>12-11-25 1723ET</p>
</div>

Corbus 制药控股公司的股票在周四的表现逊于竞争对手